| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |